Private Equity Portfolio Company
Vasthera
Seoul
South Korea
https://www.vasthera.com
VasThera is a pharmaceutical company that develops synthetic therapeutics targeting the vascular hyperplasia, with a primary focus in pulmonary arterial hypertension (PAH) and other cardiovascular diseases(CVD), i.e. restenosis and atherosc...
Private Equity Owner: Shinhan Venture Investment
Acquisition Criteria
Investment Date:
Exit Date:
Status:
Add-on Acquisitions:
Industry (NAICS Code):
Testimonials
Become the next customer to share a success story about Private Equity Info's impact.
"Private Equity Info is critical to nearly every aspect of our role as an investment bank. We use it almost every day and the return on investment is clear."
Bob McCormack
"PEI is superior for our sales team. It cuts to the core. It’s the sweet spot in terms of what you’re paying and what you’re getting.”
